Synageva is currently studying the natural history of early onset (Wolman Disease) LAL Deficiency.  The information from this study is very important to the understanding of Wolman disease since it is so rare and there is no information summarized from large groups of patients available in the literature.  If you are interested in having your child’s data included in this study, please contact one of the active clinical study sites or the sponsor representative listed on http://clinicaltrials.gov/ct2/show/NCT01358370

Views: 91

Comment

You need to be a member of LAL Solace Patient Community to add comments!

Join LAL Solace Patient Community

© 2019   Created by SandorMax   Powered by

Badges  |  Report an Issue  |  Terms of Service